This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
31 Dec 2014

Rx-360 Summary of EMA Guideline on Health Based Exposure Limited in Shared Facilities

The objective of this guideline is to recommend an approach to review and evaluate pharmacological and toxicological data of individual active substances, enabling the determination of threshold levels as referred to in the GMP guideline. These levels can be used as a risk identification tool, and can also be used to justify carry over limits used in cleaning validation. This guideline should be read in conjunction with EudraLex - Volume 4 Good manufacturing practice (GMP) Guidelines, Chapter 3 and 5.

 

This final guideline has been developed as a risk identification tool to facilitate the implementation of a science and risk based approach to manufacture of medicinal products using shared manufacturing facilities in accordance with Chapters 3 and 5.



To view or download the EMA Guidance, click here

To view or download the Rx-360 Summary of the Guidance, click here

Related News